118 related articles for article (PubMed ID: 2533789)
1. Effects of booster HB vaccine in preventing hepatitis B virus infection from mother to child.
Kunitomi T; Ikeda M; Oda M; Yamada G; Eguchi K; Ubuka K; Morita H; Kurashige T
Acta Paediatr Jpn; 1989 Dec; 31(6):669-73. PubMed ID: 2533789
[TBL] [Abstract][Full Text] [Related]
2. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
3. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen.
Lee PI; Lee CY; Huang LM; Chang MH
J Pediatr; 1995 May; 126(5 Pt 1):716-21. PubMed ID: 7751994
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore.
Oon CJ; Tan KL; Goh KT; Wong-Yong L; Viegas O; McCarthy T; Chan SH; Lee HP
J Infect; 1986 Nov; 13(3):255-67. PubMed ID: 2947953
[TBL] [Abstract][Full Text] [Related]
6. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
Farmer K; Gunn T; Woodfield DG
N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
[TBL] [Abstract][Full Text] [Related]
8. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
[TBL] [Abstract][Full Text] [Related]
9. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
10. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
Lo KJ; Tsai YT; Lee SD; Wu TC; Wang JY; Chen GH; Yeh CL; Chiang BN; Yeh SH; Goudeau A
J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
[TBL] [Abstract][Full Text] [Related]
12. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure.
Lin HH; Chang MH; Chen DS; Sung JL; Hong KH; Young YC; Yang KH; Lee TY
Vaccine; 1991 Jun; 9(6):457-60. PubMed ID: 1832257
[TBL] [Abstract][Full Text] [Related]
13. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1986 Jun; 4(1):33-6. PubMed ID: 3730058
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.
Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Chitinand S; Sakulramrung R; Tannirundorn Y
Vaccine; 1990 Mar; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286
[TBL] [Abstract][Full Text] [Related]
16. Mass protection program of perinatal hepatitis B virus infection in Japan and impact of an optional booster vaccination on its efficacy.
Tajiri H; Kozaiwa K; Harada T; Ozaki Y; Miki K; Shimizu K; Okada S
Acta Paediatr Jpn; 1991 Jun; 33(3):323-6. PubMed ID: 1785327
[TBL] [Abstract][Full Text] [Related]
17. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
[TBL] [Abstract][Full Text] [Related]
18. National project on the prevention of mother-to-infant infection by hepatitis B virus in Japan.
Eto T; Shiraki K
Acta Paediatr Jpn; 1989 Dec; 31(6):681-4. PubMed ID: 2533791
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
